MAR 02, 2020 9:10 AM PST

Bluetooth-enabled skin patch monitors diabetics' glucose levels

WRITTEN BY: Tara Fernandez

A new wearable skin patch could completely transform the daily glucose tracking routines for diabetics. This innovation, developed by the UK-based company Nemaura Medical, transmits data on circulating glucose to a mobile app via Bluetooth every five minutes. This continuous glucose monitor (CGM), named sugarBEAT®, is both non-invasive and inexpensive, making it a considerable step-up from traditional CGM devices

At just one millimeter in thickness, the disposable sugarBEAT® skin patch is designed to be inconspicuous and comfortable for use during an individual’s waking hours. A closer look at the mechanics of the device reveals tiny electronic currents that draw interstitial fluid from tissues towards the surface of the skin. The amount of glucose present in this liquid is indicative of its concentration in the blood, with the device alerting the wearer to take the required measures to stabilize glucose levels as needed.

 

 

CEO of Nemaura, Faz Chowdhury, said: “We believe that most people with diabetes do not currently use any continuous glucose monitoring system due to the high costs and the invasiveness of current products. We believe that sugarBEAT® changes this paradigm and is the first non-invasive CGM to provide the [masses] an option for daily monitoring whenever they choose at an affordable price point.”

Recently, the biotech announced plans to conduct several studies in 2020 to demonstrate the feasibility of the device as an alternative or complementary method for managing diabetes.

Researchers predict a staggering 463 million people suffer from diabetes worldwide, with that number set to spike considerably in the next decade. Keeping an eye on glucose levels and adjusting them regularly with a reliable CGM system is a fundamental part of controlling the progression of diabetes, together with lifestyle changes and pharmaceutical interventions.

Optimistic of the device’s revolutionary potential, Chowdhury said, “We believe that sugarBEAT®'s flexibility empowers users with very powerful trend data at a lower cost compared to current CGM's, which we believe will encourage broad adoption of the system"

 

Sources: Streetwise Reports, Nemaura Medical

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 18, 2020
Clinical & Molecular DX
Nerve Damage as a Prognostic Marker for Rare Autoimmune Disease
NOV 18, 2020
Nerve Damage as a Prognostic Marker for Rare Autoimmune Disease
Researchers have identified a new prognostic biomarker for Guillain-Barré syndrome (GBS), a rare autoimmune disor ...
JAN 26, 2021
Clinical & Molecular DX
Prostate Cancer Screening: No More False Positives
JAN 26, 2021
Prostate Cancer Screening: No More False Positives
A new diagnostic test powered by artificial intelligence has been found to detect prostate cancer markers in urine sampl ...
JAN 26, 2021
Cardiology
Your Nose Could Tell You Something About Your Heart Health
JAN 26, 2021
Your Nose Could Tell You Something About Your Heart Health
As we get older, many things change in our bodies. We lose touch with the newest fashion trends, or which new phone is b ...
FEB 03, 2021
Immunology
Severely Ill COVID-19 Patients may have Longer Immunity Against the Virus
FEB 03, 2021
Severely Ill COVID-19 Patients may have Longer Immunity Against the Virus
Researchers are still studying how long a person can stay immune against COVID-19 following infection. A new study by a ...
FEB 09, 2021
Clinical & Molecular DX
Make Tissues Transparent to Spot Hidden Tumors, Let Machines Do the Rest
FEB 09, 2021
Make Tissues Transparent to Spot Hidden Tumors, Let Machines Do the Rest
A clearly defined border differentiates benign tumors from malignant ones. Malignant tumors start to get fuzzy around th ...
MAR 02, 2021
Clinical & Molecular DX
Test Before You Travel: Tiny Smartphone Device Checks for COVID in 60 Minutes
MAR 02, 2021
Test Before You Travel: Tiny Smartphone Device Checks for COVID in 60 Minutes
According to the CDC’s latest travel regulations, all air passengers must have a negative COVID test before boardi ...
Loading Comments...